People 65 years and older are at a higher risk of developing flu complications. It is estimated that 70-85% of flu-related deaths occur in people over the age of 65, and between 50-70% of flu-related hospitalizations have occurred in people of this group. Studies have shown that, in this age group, higher dose or adjuvanted influenza vaccines are more effective than standard dose flu vaccines. For the 2022-23 Flu Season, the CDC and ACIP recommend people in this age group to get one of three influenza vaccines:
- Fluzone High-Dose Quadrivalent Vaccine (HD-IIV4)
- Fluad Quadrivalent Adjuvanted Vaccine (aIIV4)
- Flublok Quadrivalent Recombinant Vaccine (RIV4)
|Fluzone High-Dose – Single 0.7 mL injection into deltoid||Fluad – Single 0.5 mL injection into deltoid||Flublok – Single 0.5 mL injection into deltoid|
Some of the most common side effects include:
- Injection-site Redness, Swelling and Pain
- Runny Nose
- Body Aches
Flu & People 65 Years and Older (cdc.gov)
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2022-23 Summary of Recommendations (cdc.gov)
- Fluzone High-Dose Quadrivalent [package insert]. Swiftwater, PA: Sanofi Pasteur Inc. https://www.fda.gov/media/139731/download. Updated July 5, 2022. Accessed August 31, 2022.
- FLUAD QUADRIVALENT [package insert]. Summit, NJ: Seqirus USA Inc. https://www.fda.gov/media/135432/download. Updated July 5, 2022. Accessed August 31, 2022.
- Flublok Quadrivalent [package insert]. Swiftwater, PA: Sanofi Pasteur Inc. https://www.fda.gov/media/123144/download. Updated July 5, 2022. Accessed August 31, 2022.